药物输送系统:进入主流
Theresa M Allen1, Pieter R Cullis
1Department of Pharmacology, University of Alberta, Edmonton T6G 2H7, Canada. terry.allen@ualberta.ca
概括
使用纳米颗粒的药物输送系统 (DDS) 增强了药物的药物特性,用于亲肠道输送. 已批准的DDS配方和对新药输送的兴趣突出了它们的治疗潜力.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 药理学 药理学是指药理学的学科.
背景情况:
- 颗粒物药物递送系统 (DDS) 在临床应用中面临着挑战.
- 基于脂质和聚合物的纳米颗粒为亲肠道给药提供了改善的药物特性.
- 几种DDS配方用于抗癌和抗真菌药物已获得临床批准.
研究的目的:
- 审查药物输送系统的进步和应用.
- 突出DDS在新疗法中的潜力.
- 讨论DDS在带向疗法中的使用.
主要方法:
- 对基于纳米粒子的药物输送系统现有文献的审查.
- 对已批准的临床DDS配方进行分析.
- 探索蛋白质组学,基因组学和向治疗中的新兴应用.
主要成果:
- 在克服粒子DDS的早期挑战方面取得了重大进展.
- 已批准的DDS配方证明了这些系统的临床可行性.
- 越来越多的兴趣存在于利用DDS用于新药候选药物和有针对性的输送.
结论:
- 药物输送系统,特别是基于纳米粒子的药物输送系统,已经显著成熟.
- DDS对于提高亲肠道药物的有效性和安全性至关重要.
- 未来DDS的应用对个性化医疗和先进治疗有希望.
相关概念视频
Drug Delivery: Enteral Route
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
Drugs in...
Drugs in...
Cellular Membranes and Drug Transport
Drugs must traverse multiple biological barriers, such as multi-layered skin, single-layered intestinal epithelium, and the plasma membrane, to reach their target sites within the body. The plasma membrane, a highly structured composite of phospholipids, carbohydrates, and proteins, is the cell's protective boundary, facilitating selective substance exchange.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
Mechanisms of Drug Absorption: Paracellular, Transcellular, and Vesicular Transport
Drugs need to permeate cell membranes to reach their target sites after administration. Orally administered drugs must transcend intestinal epithelial membrane barriers to infiltrate the systemic circulation. Drugs with a molecular weight of less than 500 Daltons diffuse through gaps between neighboring cells, called paracellular pathways.
However, most drugs use the transcellular route, traversing directly through the cell membranes via two mechanisms: passive and active transport. Passive...
However, most drugs use the transcellular route, traversing directly through the cell membranes via two mechanisms: passive and active transport. Passive...
Oral Drug Delivery Systems: Continuous-Release Systems
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...
Transdermal Drug Delivery Systems
Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...


